Sort   by:  
 Page size 
UnknownThe number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.
Not available
S-EPMC7934240 | biostudies-literature
UnknownLongitudinal evaluation of retinal neuroaxonal loss in epilepsy using optical coherence tomography.
Not available
S-EPMC11647422 | biostudies-literature
UnknownThe role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.
Not available
S-EPMC7439002 | biostudies-literature
UnknownCCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites.
Not available
S-EPMC12181267 | biostudies-literature
UnknownTreatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.
Not available
S-EPMC12789025 | biostudies-literature
UnknownThe selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Not available
S-EPMC5553670 | biostudies-literature
UnknownDefining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.
Not available
S-EPMC5940636 | biostudies-literature
UnknownSynergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures.
Not available
S-EPMC6795182 | biostudies-literature
UnknownSecondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
Not available
S-EPMC4895174 | biostudies-literature
UnknownThe EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Not available
S-EPMC7387299 | biostudies-literature
Sort   by:  
 Page size